Emergency departments are required by law to treat anyone who comes through the door. But the financial model behind that guarantee is under strain. 

In this episode of "Podnosis," Fierce Healthcare and Life Sciences Editor-in-Chief Ayla Ellison talks with Tony Cirillo, M.D., president of the American College of Emergency Physicians, about the business of emergency medicine—who pays, how much, and what happens when the math stops working.

To learn more about the topics in this episode: 
Without new financial support, emergency departments, physicians struggle to meet rising demand: RAND
Op-ed: What if the ER is the emergency?
Op-ed: Emergency physicians are holding the line, but we can't do it alone

Emergency departments are required by law to treat anyone who comes through the door. But the financial model behind that guarantee is under strain.&nbsp;
In this episode of "Podnosis," Fierce Healthcare and Life Sciences Editor-in-Chief Ayla Ellison talks with Tony Cirillo, M.D., president of the American College of Emergency Physicians, about the business of emergency medicine&mdash;who pays, how much, and what happens when the math stops working.
To learn more about the topics in this episode:&nbsp;
<ul>
<li><a href="https://www.fiercehealthcare.com/providers/without-new-financial-support-emergency-departments-physicians-struggle-meet-rising">Without new financial support, emergency departments, physicians struggle to meet rising demand: RAND</a></li>
<li><a href="https://www.fiercehealthcare.com/providers/op-ed-what-if-er-emergency">Op-ed: What if the ER is the emergency?</a></li>
<li><a href="https://www.fiercehealthcare.com/providers/op-ed-emergency-physicians-are-holding-line-we-cant-do-it-alone">Op-ed: Emergency physicians are holding the line, but we can't do it alone</a></li>
</ul>

Podnosis: the pulse of the healthcare industry. Every week, journalists from Fierce Healthcare dive into some of the industry’s biggest trends. We talk to the experts about what’s important now so you can prep for the future. Hear about all things healthcare, from physician practices to hospital chains and insurance giants—and those that mix all three—plus the tech they use, disruptors looking to compete and people moving the sector forward. Follow Podnosis on Apple Podcasts, Spotify, Amazon or wherever you get your podcasts.

Podnosis: the pulse of the healthcare industry. Every week, journalists from Fierce Healthcare dive into some of the industry’s biggest trends. We talk to the experts about what’s important now so you can prep for the future. Hear about all things healthcare, from physician practices to hospital chains and insurance giants—and those that mix all three—plus the tech they use, disruptors looking to compete and people moving the sector forward. Follow Podnosis on Apple Podcasts, Spotify, Amazon or wherever you get your podcasts.

Podnosis

Podnosis: the pulse of the healthcare industry. Every week, journalists from Fierce Healthcare dive into some of the industry’s biggest trends. We talk to the experts about what’s important now so you can prep for the future. Hear about all things healthcare, from physician practices to hospital chains and insurance giants—and those that mix all three—plus the tech they use, disruptors looking to compete and people moving the sector forward. Follow Podnosis on Apple Podcasts, Spotify, Amazon or wherever you get your podcasts.

Inside the economics of emergency medicine

In this sponsored episode of Podnosis, experts examine how molecular residual disease testing is transforming how clinicians assess recurrence risk in triple-negative breast cancer. Drawing on new data from the NSABP B-59 substudy presented at SABCS and AACR, the discussion highlights how circulating tumor DNA is providing earlier and more precise insight into patient outcomes.

Dr. Priya Rastogi, chief medical officer of the NSABP Foundation, explains how MRD testing can detect residual disease that standard tools may miss, often months or years before clinical recurrence. The conversation explores key findings, including the strong correlation between post-surgical ctDNA positivity and recurrence risk, as well as the prognostic value of ctDNA status earlier in the treatment pathway.

In this sponsored episode of Podnosis, experts examine how molecular residual disease testing is transforming how clinicians assess recurrence risk in triple-negative breast cancer. Drawing on new data from the NSABP B-59 substudy presented at SABCS and AACR, the discussion highlights how circulating tumor DNA is providing earlier and more precise insight into patient outcomes. Dr. Priya Rastogi, chief medical officer of the NSABP Foundation, explains how MRD testing can detect residual disease that standard tools may miss, often months or years before clinical recurrence. The conversation explores key findings, including the strong correlation between post-surgical ctDNA positivity and recurrence risk, as well as the prognostic value of ctDNA status earlier in the treatment pathway.

How MRD Testing Is Reshaping Breast Cancer Risk Assessment (Sponsored)

Condoms can be purchased almost anywhere, from big retailers to small convenience stores. The same can’t be said for female birth control. One company is trying to change that.

Cadence OTC sells the morning-after pill, a cheaper alternative to Plan B. Recognizing that many communities in the U.S. are pharmacy deserts, the company is pursuing atypical distribution channels such as convenience stores and gas stations to get emergency contraceptives into the hands of more Americans. Cadence is also advocating for a daily birth control pill to be made available over the counter.

Senior Writer Anastassia Gliadkovskaya sits down with Cadence OTC co-founder and CEO Samantha Miller to discuss how this approach could reshape reproductive healthcare and what policy and awareness challenges remain.

To learn more about the topics in this episode: 
Insurers not covering 12-month contraception supply as required: study
The quiet collapse of America's reproductive health safety net
Perrigo's over-the-counter birth control launch takes flight in the US
Amid Trump victory, women's health providers see flood of orders for contraception, abortion pills

Condoms can be purchased almost anywhere, from big retailers to small convenience stores. The same can&rsquo;t be said for female birth control. One company is trying to change that.
Cadence OTC sells the morning-after pill, a cheaper alternative to Plan B. Recognizing that many communities in the U.S. are pharmacy deserts, the company is pursuing atypical distribution channels such as convenience stores and gas stations to get emergency contraceptives into the hands of more Americans. Cadence is also advocating for a daily birth control pill to be made available over the counter.
Senior Writer Anastassia Gliadkovskaya sits down with Cadence OTC co-founder and CEO Samantha Miller to discuss how this approach could reshape reproductive healthcare and what policy and awareness challenges remain.
To learn more about the topics in this episode:&nbsp;
<ul>
<li><a href="https://www.fiercehealthcare.com/payers/insurers-not-covering-12-month-contraception-supply-required-study">Insurers not covering 12-month contraception supply as required: study</a></li>
<li><a href="https://www.fiercehealthcare.com/providers/quiet-collapse-americas-reproductive-health-safety-net">The quiet collapse of America's reproductive health safety net</a></li>
<li><a href="https://www.fiercepharma.com/pharma/perrigos-over-counter-birth-control-launch-takes-flight-us">Perrigo's over-the-counter birth control launch takes flight in the US</a></li>
<li><a href="https://www.fiercehealthcare.com/digital-health/amid-trump-victory-womens-health-providers-see-flood-orders-contraception-abortion">Amid Trump victory, women's health providers see flood of orders for contraception, abortion pills</a></li>
</ul>

The push to expand access to emergency contraception

Maternal and infant health remains a significant challenge across the country. To support better outcomes for both pregnant women and their babies, industry giant UnitedHealth Group is investing in doulas. Its insurance arm recently expanded a doula support program nationwide in its employer plans. 

In this episode, Fierce Senior Writer Paige Minemyer sits down with Catherine Anderson, senior vice president for health optimization strategy at UnitedHealth Group, to discuss how doulas can support the pregnancy journey and the role they can play in broader community health efforts. 

To learn more about the topics in this episode: 
UnitedHealthcare expands doula benefit to employers nationwide
Exclusive: Medicaid insurers can do more to improve maternal health access, HHS report says
Doulas, once a luxury, are increasingly covered by Medicaid—even in GOP states
Massachusetts Blues launches new doula pilot program, caregiving support

Maternal and infant health remains a significant challenge across the country. To support better outcomes for both pregnant women and their babies, industry giant UnitedHealth Group is investing in doulas. Its insurance arm recently expanded a doula support program nationwide in its employer plans.&nbsp;
In this episode, Fierce Senior Writer Paige Minemyer sits down with Catherine Anderson, senior vice president for health optimization strategy at UnitedHealth Group, to discuss how doulas can support the pregnancy journey and the role they can play in broader community health efforts.&nbsp;
To learn more about the topics in this episode:&nbsp;
<ul>
<li><a href="https://www.fiercehealthcare.com/payers/unitedhealthcare-expands-doula-benefit-employers-nationwide">UnitedHealthcare expands doula benefit to employers nationwide</a></li>
<li><a href="https://www.fiercehealthcare.com/payers/exclusive-medicaid-insurers-can-do-more-improve-maternal-health-access-hhs-report-says">Exclusive: Medicaid insurers can do more to improve maternal health access, HHS report says</a></li>
<li><a href="https://www.fiercehealthcare.com/payers/doulas-once-luxury-are-increasingly-covered-medicaid-even-gop-states">Doulas, once a luxury, are increasingly covered by Medicaid&mdash;even in GOP states</a></li>
<li><a href="https://www.fiercehealthcare.com/payers/massachusetts-blues-launches-new-doula-caregiving-support">Massachusetts Blues launches new doula pilot program, caregiving support</a></li>
</ul>

Inside the economics of emergency medicine

In 1 playlist(s)

Podnosis

Social links

Follow podcast

Recent clips